Oticon More vs Otofonix Groove

The Oticon More is a premium prescription behind-the-ear hearing aid that earns an A grade with a SoundScore of 4.6/5 in our lab testing, placing it in the top 23% of the 39 prescription hearing aids we've evaluated. Currently available at $4,598, this 2021 release has earned our Expert's Choice Award in both 2023 and 2024. In our testing, the Oticon More demonstrates strong speech clarity performance. Speech in quiet scores 4.0/5, which is 0.65 points above the category average—a meaningful advantage for everyday conversation. Speech in noise measures 2.7/5, which is 0.60 points above the category average, though the absolute score reflects the inherent challenge all hearing aids face in noisy environments. Own-voice comfort is solid at 3.1/5, sitting 0.40 points above average. The device does show one notable weakness: feedback handling scores 3.5/5, which is 1.22 points below the category average of 4.72/5. While this is still a solid score in absolute terms, competing devices in this price range generally perform better in this area. Music streaming is solid at 3.0/5, slightly above the category average. The Oticon More offers flexibility with both rechargeable and disposable battery options, plus streaming compatibility with both iPhone and Android devices including hands-free calling. For those considering alternatives, newer models like the Oticon Intent and Oticon Real score higher in our testing at similar price points. The Oticon More remains a capable choice for listeners who prioritize speech clarity and want a well-established platform with proven performance.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.